Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma
Despite the overall success of using R-CHOP for the care for non-Hodgkin’s lymphoma patients, it is clear that the disease is quite complex and new insight is needed to further stratify the patient for a better personized treatment. In current study, based on previous studies from animal model, new...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2019/7627384 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832552618439737344 |
---|---|
author | Zhenhua Xian Dehua Fu Shuang Liu Yang Yao Chun Gao |
author_facet | Zhenhua Xian Dehua Fu Shuang Liu Yang Yao Chun Gao |
author_sort | Zhenhua Xian |
collection | DOAJ |
description | Despite the overall success of using R-CHOP for the care for non-Hodgkin’s lymphoma patients, it is clear that the disease is quite complex and new insight is needed to further stratify the patient for a better personized treatment. In current study, based on previous studies from animal model, new panels combining well-established cytokine (BAFF) and autoantibodies (anti-SSA/Ro) with newly identified cytokine (IL14) and autoantibodies (TSA) were used to evaluate the association between B cell growth factor and Sjögren’s related autoantibodies in NHL patients. The result clearly indicates that there was a unique difference between BAFF and IL14 in association with autoantibodies. While serum BAFF was negatively associated with the presence of both traditional anti-SSA/Ro and novel TSA antibodies in GI lymphoma patient, IL14 was positively associated with the presence of both traditional anti-SSA/Ro and novel TSA antibodies in non-GI lymphoma patient. Long-term follow-ups on these patients and evaluation of their response to the R-CHOP treatment and recurrence rate will be very interesting. Our result provides a solid evidence to support using novel diagnostic panel to better stratify the NHL patients. |
format | Article |
id | doaj-art-140153f2e8d34906beca512838d3d9a5 |
institution | Kabale University |
issn | 2314-8861 2314-7156 |
language | English |
publishDate | 2019-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Immunology Research |
spelling | doaj-art-140153f2e8d34906beca512838d3d9a52025-02-03T05:58:16ZengWileyJournal of Immunology Research2314-88612314-71562019-01-01201910.1155/2019/76273847627384Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s LymphomaZhenhua Xian0Dehua Fu1Shuang Liu2Yang Yao3Chun Gao4Department of Gastrointestinal Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Gastrointestinal Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Gastrointestinal Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Gastrointestinal Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Gastrointestinal Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, ChinaDespite the overall success of using R-CHOP for the care for non-Hodgkin’s lymphoma patients, it is clear that the disease is quite complex and new insight is needed to further stratify the patient for a better personized treatment. In current study, based on previous studies from animal model, new panels combining well-established cytokine (BAFF) and autoantibodies (anti-SSA/Ro) with newly identified cytokine (IL14) and autoantibodies (TSA) were used to evaluate the association between B cell growth factor and Sjögren’s related autoantibodies in NHL patients. The result clearly indicates that there was a unique difference between BAFF and IL14 in association with autoantibodies. While serum BAFF was negatively associated with the presence of both traditional anti-SSA/Ro and novel TSA antibodies in GI lymphoma patient, IL14 was positively associated with the presence of both traditional anti-SSA/Ro and novel TSA antibodies in non-GI lymphoma patient. Long-term follow-ups on these patients and evaluation of their response to the R-CHOP treatment and recurrence rate will be very interesting. Our result provides a solid evidence to support using novel diagnostic panel to better stratify the NHL patients.http://dx.doi.org/10.1155/2019/7627384 |
spellingShingle | Zhenhua Xian Dehua Fu Shuang Liu Yang Yao Chun Gao Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma Journal of Immunology Research |
title | Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma |
title_full | Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma |
title_fullStr | Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma |
title_full_unstemmed | Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma |
title_short | Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma |
title_sort | association between b cell growth factors and primary sjogren s syndrome related autoantibodies in patients with non hodgkin s lymphoma |
url | http://dx.doi.org/10.1155/2019/7627384 |
work_keys_str_mv | AT zhenhuaxian associationbetweenbcellgrowthfactorsandprimarysjogrenssyndromerelatedautoantibodiesinpatientswithnonhodgkinslymphoma AT dehuafu associationbetweenbcellgrowthfactorsandprimarysjogrenssyndromerelatedautoantibodiesinpatientswithnonhodgkinslymphoma AT shuangliu associationbetweenbcellgrowthfactorsandprimarysjogrenssyndromerelatedautoantibodiesinpatientswithnonhodgkinslymphoma AT yangyao associationbetweenbcellgrowthfactorsandprimarysjogrenssyndromerelatedautoantibodiesinpatientswithnonhodgkinslymphoma AT chungao associationbetweenbcellgrowthfactorsandprimarysjogrenssyndromerelatedautoantibodiesinpatientswithnonhodgkinslymphoma |